Every SEC Form 3/4/5 on record for this filer (CIK 1899935) — 4 issuers, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| KALV | KalVista Pharmaceuticals, Inc. | Director | 2025-10-02 → 2026-06-11 | 3 | — |
| ACOG | Alpha Cognition Inc. | Director | 2026-04-17 → 2026-04-17 | 2 | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Director | 2023-08-21 → 2026-02-23 | 8 | −$455,105 |
| NMTR | 9 METERS BIOPHARMA, INC. | Chief Financial Officer · lapsed | 2022-01-18 → 2023-04-21 | 4 | −$11,011 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| SUPN | 2026-02-19 | Sell | 3,258 | $51.27 | $167,038 | — |
| SUPN | 2026-02-19 | Sell | 1,217 | $50.31 | $61,227 | 3,258 |
| SUPN | 2025-08-14 | Sell | 5,369 | $42.25 | $226,840 | — |
| NMTR | 2023-04-21 | Sell | 9,100 | $1.21 | $11,011 | 41,077 |
2 of 4 issuers are covered and open a security page; the rest are on file here only.
